Exicure, Inc.
Support and Resistance Levels
Past performance
News About XCUR
All events for XCUR
All deals for XCUR
Financial Ratios
Financial Statements
XCUR vs Sector & Peers
About Exicure, Inc.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Website exicuretx.com
Headquarters Redwood City, CA, US